14.07.2017
- The UK Supreme Court has ruled in favor of US drugmaker Eli Lilly in a patent dispute with generics producer Actavis, now owned by Israel’s Teva, over the cancer drug Alimta. The...
10.02.2017
- Israeli drugmaker – the world’s largest generics producer – has moved into the spotlight again, days after it said it was replacing its CEO Erez Vigodman. According to the Israeli...
08.02.2017
- Erez Vigodman and the board of Israel’s Teva Pharmaceutical Industries – the world’s largest generics drugmaker – have announced that the chief executive, who has led the company...
07.02.2017
- US drugmaker Mylan is facing a probe from the Federal Trade Commission (FTC) as to whether it has violated antitrust laws in protecting its EpiPen from lower-priced competitors...
31.01.2017
- US company Barr Laboratories, a subsidiary of Israeli drugmaker Teva, has reached a $225 million settlement in an antitrust class action that accused Teva of keeping a generic...
09.12.2016
- Shares of Israeli drugmaker Teva took a hit earlier this week when the company announced that its generics CEO, Siggi Olafsson, was leaving the company and would be replaced by...
02.11.2016
- Israel’s Teva Pharmaceutical Industries and US technology conglomerate IBM have expanded their existing global e-Health alliance to focus on two key healthcare challenges – the...
07.10.2016
- Israel’s Teva Pharmaceutical Industries is planning to sell the assets of Actavis Generics in the UK and Ireland to Accord Healthcare, a subsidiary of India’s Intas Pharmaceuticals...
